メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
Keio University ホーム
ヘルプ＆FAQ
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
医学教育統轄センター
学部
医学部
概要
フィンガープリント
ネットワーク
プロファイル
(6)
研究成果
(553)
フィンガープリント
医学教育統轄センターが活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Helicobacter Pylori
100%
Aldosterone Synthase
44%
Cross Sectional Study
44%
Pylorus
42%
Stomach Cancer
39%
Helicobacter Infection
39%
Primary Hyperaldosteronism
38%
Meta-Analysis
38%
Aldosterone
37%
Pancreas Cancer
36%
Disease
36%
Symptom
35%
Neoplasm
34%
Pancreas Adenocarcinoma
34%
Odds Ratio
28%
Proton-Pump Inhibitor
27%
Systematic Review
25%
Dyspepsia
23%
Peritoneal Dialysis
23%
Surgery
23%
Gastritis
22%
Diagnosis
22%
Endoscopic Submucosal Dissection
21%
Hemodialysis
21%
Infection
20%
Liver Transplantation
19%
Nicotinamide Adenine Dinucleotide
19%
Eradication Therapy
19%
Upper Gastrointestinal Bleeding
19%
Malignant Neoplasm
19%
Systemic Lupus Erythematosus
18%
Immunohistochemistry
17%
Adrenal
16%
Primary Health Care
16%
Stomach Mucosa
16%
Hepatectomy
16%
Computer Assisted Tomography
16%
Pancreaticoduodenectomy
15%
Zona Glomerulosa
14%
Intraductal Papillary Mucinous Tumor
14%
microRNA
14%
Ulcer
14%
Pathophysiology
13%
Stomach Ulcer
13%
Prevalence
13%
Bleeding
13%
Jejunum Ulcer
12%
Microcirculation
12%
Metastatic Carcinoma
12%
Cholangiocarcinoma
12%
Recurrent Disease
11%
Endoscopic Hemostasis
11%
Pancreatectomy
11%
Self-Diagnosis
11%
Adrenalectomy
11%
Gastrointestinal Endoscopy
11%
Duodenum Ulcer
11%
Stomach Paresis
11%
Pancreas Fistula
11%
Esophageal Cancer
11%
Hazard Ratio
11%
Zonation
11%
Chemoradiotherapy
11%
Heart Failure
10%
Peritonitis
10%
Autoantibodies
10%
Hyponatremia
10%
Ghrelin
10%
Zona fasciculata
10%
Somatics
10%
Adenoma
10%
Liver Cirrhosis
10%
Adipocyte
10%
Endoscopy
10%
Fibroblast
10%
Retrospective Cohort Study
10%
Medical Student
10%
Myeloperoxidase
10%
Hepatocellular Carcinoma
9%
Adrenal Gland
9%
KCNJ5
9%
Propofol
9%
Oxidative Stress
9%
Interstitial Nephritis
9%
Bile Leakage
9%
Hepatic Vein
9%
Cognition
9%
Cell Transdifferentiation
9%
Rikkunshito
9%
Blood Stasis
9%
COVID-19
9%
Dilated Cardiomyopathy
9%
Tryptophan
9%
Immunoabsorption
9%
Stomach Disease
9%
Eosinophilia
9%
Inflammatory Bowel Disease
9%
Social Determinants of Health
9%
Visceral Fat
9%
Dexmedetomidine
9%
Pharmacology, Toxicology and Pharmaceutical Science
Helicobacter Pylori
85%
Helicobacter Infection
55%
Infection
41%
Disease
35%
Dyspepsia
28%
Pancreas Adenocarcinoma
24%
Gastritis
23%
Stomach Cancer
22%
Clarithromycin
22%
Mouse
21%
Symptom
20%
Carbon 13
19%
Amoxicillin
19%
Prevalence
18%
Ethanol
18%
Pancreas Cancer
18%
Pathophysiology
16%
Connective Tissue Disease
16%
Jejunum Ulcer
15%
Proton Pump Inhibitor
14%
Myositis
14%
Potassium Competitive Acid Blocker
14%
Methotrexate
14%
Ghrelin
14%
Social Determinants of Health
14%
Nicotinamide Nucleotide
14%
Inflammation
13%
Malignant Neoplasm
13%
Autoantibodies
13%
Stomach Ulcer
13%
Amino Acid Transfer RNA Ligase
12%
Ulcer
12%
Sitafloxacin
11%
Neoplasm
11%
Polymyositis
11%
Rheumatoid Arthritis
11%
Nicotinamide Adenine Dinucleotide
11%
Injury
11%
Rifabutin
11%
Stomach Paresis
11%
Retrospective Study
11%
Interstitial Pneumonia
10%
Hyponatremia
10%
Lansoprazole
10%
Hemodialysis
10%
Gastroesophageal Reflux
10%
Urease
10%
Cross-Sectional Study
10%
Metronidazole
9%
Alcohol Dehydrogenase
9%
Fluorouracil
9%
Acotiamide
9%
Calcidiol 1 Monooxygenase
9%
Oxidoreductase
9%
Leptin
9%
Corticosteroid Induced Osteoporosis
9%
Interstitial Lung Disease
9%
Congestive Cardiomyopathy
9%
Tryptophan
9%
Propofol
9%
Dexmedetomidine
9%
Cohort Study
9%
Chemoradiation Therapy
9%
Combination Therapy
9%
Adverse Event
9%
Vonoprazan
8%
Urea Breath Test
8%
Dermatomyositis
8%
Biological Marker
8%
Pepsinogen I
8%
Synthetase
7%
Knockout Mouse
7%
Gastric Mucosa
7%
Normal Human
7%
Clinical Trial
7%
Chronic Kidney Failure
7%
Reactive Oxygen Metabolite
7%
Esomeprazole
7%
Ulcer Healing
6%
Immunoglobulin G3
6%
Heart Failure
6%
Antibiotics
6%
Metastasis
6%
microRNA
6%
Esophageal Adenocarcinoma
6%
Liver Cell Carcinoma
6%
Systemic Sclerosis
6%
Meriones unguiculatus
6%
Mouse Model
6%
Xanthine Oxidase
5%
Antibiotic Therapy
5%
Carbon Monoxide
5%
Thiazide Diuretic Agent
5%
Rat Model
5%
Glutathione
5%
Oxygen Radical
5%
Corticosterone
5%
Complementary DNA
5%
Placebo
5%
Infectious Complication
5%
Keyphrases
Helicobacter Pylori (H. pylori)
49%
Helicobacter Pylori Eradication
27%
Gastric Cancer
27%
Japan
26%
Helicobacter Pylori Infection
26%
Autoantibodies
24%
CYP11B2
20%
Confidence Interval
19%
Connective Tissue Disease
19%
Proton Pump Inhibitors
16%
Pancreatic Ductal Adenocarcinoma
15%
Functional Dyspepsia
14%
Plasma Ghrelin
14%
Metastatic Pancreatic Ductal Adenocarcinoma
13%
Ghrelin Level
13%
Primary Aldosteronism
12%
Gastritis
12%
CYP11B1
11%
Family Caregivers
11%
Patients with Functional Dyspepsia
11%
Eradication Therapy
11%
Japanese Patients
11%
Family Caregiver Experiences
11%
Pepsinogen
10%
Nephrotic Syndrome
10%
Gastric Atrophy
10%
Duodenal Ulcer
9%
Collaborative Care
9%
Ribonucleoprotein
9%
RdxA
9%
Metronidazole Resistance
9%
Alcohol Metabolism
9%
Breath Test
9%
Liver Transplantation
9%
East Asian Countries
9%
Rikkunshito
9%
Glucocorticoid-induced Osteoporosis
9%
Etidronate
9%
Rat Liver
9%
Questionnaire Survey
9%
Interstitial Lung Disease
9%
Pancreatic Neuroendocrine Tumors (pNETs)
9%
Gastric Diseases
9%
Adrenal Zonation
9%
Meta-analysis
9%
Postprandial Glucose Metabolism
9%
Idiopathic Inflammatory Myopathies
9%
KRAS mutation
9%
Borderline Resectable Pancreatic Cancer
9%
Clinical Impact
9%
Neoadjuvant Chemoradiotherapy (nCRT)
9%
Extracellular Vesicles
9%
Nicotinamide Adenine Dinucleotide (NAD+)
9%
Ghrelin
8%
Caregivers
8%
Early Detection
8%
Pooled Odds Ratios
8%
Borderline Resectable
8%
Systemic Sclerosis
8%
Myeloperoxidase
8%
Oxygen Radicals
8%
Gastric Ulcer
8%
Aldosterone
7%
Gene mutation
7%
Systemic Lupus Erythematosus
7%
Inhibitor Treatment
7%
Magnetic Resonance Imaging
7%
Thrombocytopenia
7%
Antrum
7%
Pathophysiology
7%
Cortisol
7%
No Significant Difference
7%
Endoscopic Submucosal Dissection
7%
Myositis
7%
Patients with multimorbidity
7%
Delayed Gastric Emptying
6%
Gastric Carcinoma
6%
Odds Ratio
6%
Knock-in Mouse Model
6%
Hazard Ratio
6%
Randomized Trial
6%
Clinical Significance
6%
Comorbidity
6%
Kidney
6%
First-line Eradication
6%
Antinuclear Antibodies
6%
Helicobacter Pylori Gastritis
6%
Peptic Ulcer
6%
Gastrointestinal Endoscopy
6%
Chemiluminescence
6%
Serum Pepsinogen
6%
Interleukin-8
6%
Acute Kidney Injury
6%
Endoscopy
6%
Mongolian Gerbil
5%
Hyponatremia
5%
Total Ghrelin
5%
Aldosterone-producing Adenoma
5%
Xanthine Oxidase
5%
Rat Adrenal
5%